新冠患者-话题@MedSci

#新冠患者#

69篇内容 | 2569人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1906503, encodeId=5468190650375, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=新冠患者“复阳”谜局：有人不产生抗体，病毒或慢性携带, objectType=article, longId=189826, objectId=84f11898262b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84f11898262b, replyNumber=0, likeNumber=0, createdTime=2020-04-07, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84f11898262b, moduleTitle=新冠患者“复阳”谜局：有人不产生抗体，病毒或慢性携带, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84f11898262b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906532, encodeId=11361906532b4, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , objectType=article, longId=200504, objectId=f82c200504b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f82c200504b9, replyNumber=0, likeNumber=85, createdTime=2020-10-24, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f82c200504b9, moduleTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f82c200504b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906515, encodeId=964c19065153b, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=J INTERN MED：欧洲轻度至中度新冠患者的临床和流行病学特征, objectType=article, longId=193327, objectId=6e4819332e9c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4819332e9c, replyNumber=0, likeNumber=62, createdTime=2021-01-11, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4819332e9c, moduleTitle=J INTERN MED：欧洲轻度至中度新冠患者的临床和流行病学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e4819332e9c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906531, encodeId=c7be19065319f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=警惕！研究称部分新冠患者康复后粪便内病毒仍具传染性, objectType=article, longId=200415, objectId=44c02004155c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c02004155c, replyNumber=0, likeNumber=72, createdTime=2021-04-15, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c02004155c, moduleTitle=警惕！研究称部分新冠患者康复后粪便内病毒仍具传染性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44c02004155c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906541, encodeId=bc601906541d8, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率, objectType=article, longId=205490, objectId=1f4b205490bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f4b205490bc, replyNumber=0, likeNumber=77, createdTime=2021-08-20, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f4b205490bc, moduleTitle=Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f4b205490bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906522, encodeId=bf9f190652235, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=新冠一周进展报告丨中国发布全球新冠疫苗动物实验结果；新冠患者出院后免疫系统仍脆弱, objectType=article, longId=193888, objectId=98bc193888a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98bc193888a3, replyNumber=0, likeNumber=79, createdTime=2020-11-26, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98bc193888a3, moduleTitle=新冠一周进展报告丨中国发布全球新冠疫苗动物实验结果；新冠患者出院后免疫系统仍脆弱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98bc193888a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906521, encodeId=083b1906521c1, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=临床试验显示一种三联药物疗法对轻、中度新冠患者可能有效, objectType=article, longId=193873, objectId=cd0a1938e388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd0a1938e388, replyNumber=0, likeNumber=94, createdTime=2020-09-03, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd0a1938e388, moduleTitle=临床试验显示一种三联药物疗法对轻、中度新冠患者可能有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd0a1938e388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906518, encodeId=4611190651879, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=韩国一保险机构公布新冠患者治疗费用：危重症高达七千万韩元, objectType=article, longId=193729, objectId=ffe2193e2981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffe2193e2981, replyNumber=0, likeNumber=0, createdTime=2020-06-28, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffe2193e2981, moduleTitle=韩国一保险机构公布新冠患者治疗费用：危重症高达七千万韩元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffe2193e2981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906504, encodeId=8f9619065044c, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=ATS Journals: 新冠患者症状消失8天后仍具有传染性，10月后或有疫情高峰, objectType=article, longId=191314, objectId=66d019131432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66d019131432, replyNumber=0, likeNumber=83, createdTime=2020-10-05, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66d019131432, moduleTitle=ATS Journals: 新冠患者症状消失8天后仍具有传染性，10月后或有疫情高峰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66d019131432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906517, encodeId=4a4d190651e1f, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=北大一院感染科主任：目前新冠患者复阳比例为5%到15%, objectType=article, longId=193726, objectId=5293193e2621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5293193e2621, replyNumber=0, likeNumber=62, createdTime=2020-06-06, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5293193e2621, moduleTitle=北大一院感染科主任：目前新冠患者复阳比例为5%到15%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5293193e2621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906526, encodeId=3ccd1906526a2, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=Brit J Heamatol：新冠患者的迟发性血小板减少症, objectType=article, longId=196879, objectId=1eac1968e90e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eac1968e90e, replyNumber=0, likeNumber=74, createdTime=2020-09-20, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eac1968e90e, moduleTitle=Brit J Heamatol：新冠患者的迟发性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eac1968e90e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906528, encodeId=eb81190652898, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=NEJM：正式发表！大规模随机对照试验，廉价药地塞米松可以降低新冠患者（有创通气）30%以上的死亡率, objectType=article, longId=197845, objectId=cdfb19e8458b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdfb19e8458b, replyNumber=0, likeNumber=79, createdTime=2021-01-13, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdfb19e8458b, moduleTitle=NEJM：正式发表！大规模随机对照试验，廉价药地塞米松可以降低新冠患者（有创通气）30%以上的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdfb19e8458b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906502, encodeId=5a9b190650224, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=**、二例新冠患者遗体解剖完毕，能从中发现更多有价值线索吗？, objectType=article, longId=189608, objectId=bddd1896084a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bddd1896084a, replyNumber=0, likeNumber=54, createdTime=2020-07-01, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bddd1896084a, moduleTitle=**、二例新冠患者遗体解剖完毕，能从中发现更多有价值线索吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bddd1896084a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906514, encodeId=a0a019065143e, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=河南：县级医院治愈出院新冠患者占全省三成以上, objectType=article, longId=192800, objectId=ea8119280088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea8119280088, replyNumber=0, likeNumber=78, createdTime=2020-06-04, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea8119280088, moduleTitle=河南：县级医院治愈出院新冠患者占全省三成以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea8119280088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906527, encodeId=91bd190652ea4, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体, objectType=article, longId=197337, objectId=45e619e33750, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45e619e33750, replyNumber=0, likeNumber=84, createdTime=2021-04-05, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e619e33750, moduleTitle=CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45e619e33750)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906510, encodeId=06141906510f1, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=Cardiovasc Res: 亚洲新冠患者用ACEI/ARB获益或更大！欧洲高血压学会工作组发文, objectType=article, longId=192659, objectId=324719265976, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=324719265976, replyNumber=0, likeNumber=58, createdTime=2020-06-03, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=324719265976, moduleTitle=Cardiovasc Res: 亚洲新冠患者用ACEI/ARB获益或更大！欧洲高血压学会工作组发文, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=324719265976)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906507, encodeId=5a2f190650e09, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=Nat Med：新冠患者传染性始于症状出现前2.3天，发病前0.7天达到峰值, objectType=article, longId=192435, objectId=db3d19243519, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db3d19243519, replyNumber=0, likeNumber=60, createdTime=2020-08-01, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db3d19243519, moduleTitle=Nat Med：新冠患者传染性始于症状出现前2.3天，发病前0.7天达到峰值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db3d19243519)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906505, encodeId=787a19065058d, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=国务院印发服务方案：做好新冠患者、隔离人员及家属心理疏导, objectType=article, longId=191777, objectId=feb6191e7780, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feb6191e7780, replyNumber=0, likeNumber=69, createdTime=2020-08-13, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feb6191e7780, moduleTitle=国务院印发服务方案：做好新冠患者、隔离人员及家属心理疏导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feb6191e7780)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906525, encodeId=747c19065253d, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=【Nature】冠状病毒大突破：地塞米松，可以挽救重症新冠患者生命的药物, objectType=article, longId=196089, objectId=358319608965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=358319608965, replyNumber=0, likeNumber=75, createdTime=2021-01-23, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=358319608965, moduleTitle=【Nature】冠状病毒大突破：地塞米松，可以挽救重症新冠患者生命的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=358319608965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1906520, encodeId=6895190652074, content=<a href='/topic/show?id=317e5805e9d' target=_blank style='color:#2F92EE;'>#新冠患者#</a>, objectTitle=**对话陈静瑜：新冠患者肺移植国家队完成医疗救治最后一棒, objectType=article, longId=193865, objectId=7a56193865f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a56193865f0, replyNumber=0, likeNumber=0, createdTime=2020-06-06, rootId=0, userName=tidiq, userId=b3e9205, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a56193865f0, moduleTitle=**对话陈静瑜：新冠患者肺移植国家队完成医疗救治最后一棒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a56193865f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新冠患者

2020-05-29

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

新冠患者“复阳”谜局：有人不产生抗体，病毒或慢性携带

2020-04-07

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究

2020-10-24

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

J INTERN MED：欧洲轻度至中度新冠患者的临床和流行病学特征

2021-01-11

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

警惕！研究称部分新冠患者康复后粪便内病毒仍具传染性

2021-04-15

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

Cell Metabolism :突破！武汉大学李红良等团队首次解决了全球糖皮质激素治疗新冠用药难题，有望降低新冠患者死亡率

2021-08-20

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

新冠一周进展报告丨中国发布全球新冠疫苗动物实验结果；新冠患者出院后免疫系统仍脆弱

2020-11-26

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

临床试验显示一种三联药物疗法对轻、中度新冠患者可能有效

2020-09-03

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

韩国一保险机构公布新冠患者治疗费用：危重症高达七千万韩元

2020-06-28

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

ATS Journals: 新冠患者症状消失8天后仍具有传染性，10月后或有疫情高峰

2020-10-05

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

北大一院感染科主任：目前新冠患者复阳比例为5%到15%

2020-06-06

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

Brit J Heamatol：新冠患者的迟发性血小板减少症

2020-09-20

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

NEJM：正式发表！大规模随机对照试验，廉价药地塞米松可以降低新冠患者（有创通气）30%以上的死亡率

2021-01-13

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

**、二例新冠患者遗体解剖完毕，能从中发现更多有价值线索吗？

2020-07-01

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

河南：县级医院治愈出院新冠患者占全省三成以上

2020-06-04

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体

2021-04-05

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

Cardiovasc Res: 亚洲新冠患者用ACEI/ARB获益或更大！欧洲高血压学会工作组发文

2020-06-03

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

Nat Med：新冠患者传染性始于症状出现前2.3天，发病前0.7天达到峰值

2020-08-01

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

国务院印发服务方案：做好新冠患者、隔离人员及家属心理疏导

2020-08-13

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

【Nature】冠状病毒大突破：地塞米松，可以挽救重症新冠患者生命的药物

2021-01-23

tidiq (审核中...)

前往app查看评论内容

#新冠患者#

**对话陈静瑜：新冠患者肺移植国家队完成医疗救治最后一棒

2020-06-06

科室
- - 订阅+
  - 更多科室
工具
服务